These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14273321)

  • 21. Regional lung function and over-all gas exchange in chronic obstructive lung disease: the effect of intermittent positive pressure breathing with isoproterenol.
    Dawson A; Rocamora JM
    Am Rev Respir Dis; 1974 Mar; 109(3):338-44. PubMed ID: 4592451
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of tuberculin on ventilatory parameters in patients with pulmonary tuberculosis.
    Kurgan J
    Respiration; 1971; 28(4):379-88. PubMed ID: 5138486
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute effects of inhaled isoproterenol on the mechanical characteristics of the lungs in normal man.
    McFadden ER; Newton-Howes J
    J Clin Invest; 1970 Apr; 49(4):779-90. PubMed ID: 5443178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deposition of aerosols in pulmonary disease.
    Goldberg IS; Lourenço RV
    Arch Intern Med; 1973 Jan; 131(1):88-91. PubMed ID: 4682066
    [No Abstract]   [Full Text] [Related]  

  • 25. Spirometry following glucagon and isoproterenol in chronic obstructive lung disease.
    Al-Naggar M; Collins VJ
    Middle East J Anaesthesiol; 1974 Oct; 4(3):197-204. PubMed ID: 4480610
    [No Abstract]   [Full Text] [Related]  

  • 26. Response of patients with chronic obstructive lung disease to the regular administration of nebulized isoproterenol. A double-blind crossover study.
    Light RW; Summer WR; Luchsinger PC
    Chest; 1975 Jun; 67(6):634-9. PubMed ID: 1092531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pulmonary hemodynamic effects of aerosols of isoproterenol and ipratropium in normal subjects and patients with reversible airway obstruction.
    Sackner MA; Friedman M; Silva G; Fernandez R
    Am Rev Respir Dis; 1977 Dec; 116(6):1013-22. PubMed ID: 145195
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolonged effects of viral infections of the upper respiratory tract upon small airways.
    Picken JJ; Niewoehner DE; Chester EH
    Am J Med; 1972 Jun; 52(6):738-46. PubMed ID: 5030171
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of expiratory forced flows for determining response to bronchodilator therapy.
    Boushy SF
    Chest; 1972 Nov; 62(5):534-41. PubMed ID: 4563061
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of the effects of isoetharine and some other adrenergic beta-stimulators in chronic obstructive lung disease.
    Thiringer G; Bergh NP; Svedmyr N
    Scand J Respir Dis; 1971; 52(4):183-91. PubMed ID: 5161421
    [No Abstract]   [Full Text] [Related]  

  • 31. Ultrasonic nebulization of water and mucoevacuant solutions in patients with obstructive lung disease: volumetric and ventilatory responses to acute administration.
    Cohen BM
    Respiration; 1972; 29(1):51-60. PubMed ID: 4553225
    [No Abstract]   [Full Text] [Related]  

  • 32. [AN AMBULATORY METHOD FOR THE STUDY OF BRONCHOLYTIC AGENTS IN EXPERIMENTAL BRONCHIAL SPASM].
    BEUMER HM
    Med Thorac; 1964; 21():52-64. PubMed ID: 14185072
    [No Abstract]   [Full Text] [Related]  

  • 33. Dose response of patients with asthma to inhaled isoproterenol.
    Williams MH; Kane C
    Am Rev Respir Dis; 1975 Mar; 111(3):321-4. PubMed ID: 1119742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical results of the phenylephrine, isoprenaline, and atropine association in the treatment of obstructive respiratory insufficiency].
    Pino G; Rovera R; Cozza G
    Minerva Med; 1972 Jan; 63(5):308-19. PubMed ID: 4551951
    [No Abstract]   [Full Text] [Related]  

  • 35. [Methods of respiratory therapy in respiratory insufficiency of patients with bronchopulmonary diseases (guidelines)].
    Zhilin IuN
    Probl Tuberk; 1990; (9):46-9. PubMed ID: 2274510
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of heparin aerosols on airway conductance in patients with chronic obstructive pulmonary disease.
    Youngchaiyud P; Kettel LJ; Cugell DW
    Am Rev Respir Dis; 1969 Mar; 99(3):449-52. PubMed ID: 5765638
    [No Abstract]   [Full Text] [Related]  

  • 37. Nebulized bronchodilators in obstructive lung disease. II.
    Sheldon GP
    Ann Allergy; 1972 Feb; 30(2):69-85. PubMed ID: 4551435
    [No Abstract]   [Full Text] [Related]  

  • 38. What does airway resistance tell us about lung function?
    Kaminsky DA
    Respir Care; 2012 Jan; 57(1):85-96; discussion 96-9. PubMed ID: 22222128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerosolized detergents and mucolytic agents in the treatment of stable chronic obstructive pulmonary disease.
    Barton AD
    Am Rev Respir Dis; 1974 Dec; 110(6 Pt 2):104-10. PubMed ID: 4613216
    [No Abstract]   [Full Text] [Related]  

  • 40. COMPARISON BETWEEN EFFECTS OF SOME AEROSOLS WITH ANTIASTHMATIC EFFECT ON THE AIRFLOW IN ASTHMA AND EMPHYSEMA.
    SVANBORG N
    Acta Allergol; 1964; 19():316-24. PubMed ID: 14206145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.